|
Volumn 12, Issue 17, 1998, Pages 2355-2356
|
Pneumocystis carinii prophylaxis can be discontinued after CD4+ cell recovery over 200 x 106/l [5]
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
COTRIMOXAZOLE;
SULFONAMIDE;
ADULT;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MALE;
PNEUMOCYSTIS CARINII;
PNEUMOCYSTOSIS;
PRIORITY JOURNAL;
ADULT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
CD4 LYMPHOCYTE COUNT;
FEMALE;
HUMANS;
MALE;
PNEUMONIA, PNEUMOCYSTIS;
RETROSPECTIVE STUDIES;
|
EID: 0032480911
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (10)
|
References (4)
|